SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …

… Ina Mexhitaj; Ina Mexhitaj … Salgado, Ina Mexhitaj, Simone C. Wuest, Elena Romm, Joan
Ohayon, Raphaela Goldbach-Mansky, Adeline Vanderver, Adriana Marques, Camilo Toro, Peter …

A small proportion of multiple sclerosis (MS) patients develop new disease activity soon
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …

Elucidation of distinct T-cell subsets involved in multiple sclerosis immune-pathophysiology
continues to be of considerable interest since an ultimate goal is to more selectively target …

Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system (CNS).
Neither the antigenic target(s) nor the cell population(s) responsible for CNS tissue …

Abstract Analysis of cerebrospinal fluid (CSF) represents a valuable window into the pathogenesis
of neuroinflammatory diseases, such as multiple sclerosis (MS). However, analysis of …

Background: Being obese is associated with both increased risk of developing multiple
sclerosis (MS) and greater MS disease activity. Objectives: The objective of this study is to …

Methamphetamine (METH) is an addictive agent that poses a public health problem due to
its toxic effects on neural tissue. We have shown that METH induces striatal lesions (cell loss) …

A large body of evidence shows that methamphetamine (METH) causes sustained damage
to the brain in animal models and human METH users. In chronic users there are indications …

Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system (CNS),
which leads to accumulating neurological disability. Available therapies can ease symptoms …